Eugene M. Johnston

CIK: 0001254538

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

OFAL

OFA Group

Officer

MGRX

MANGOCEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

MGRX
MANGOCEUTICALS, INC.
Jul 28, 2026
Award(A)
Direct
100K shares-
MGRX
MANGOCEUTICALS, INC.
Dec 15, 2025
Sale(S)
Direct
3.3K shares at avg. $1.17$4K
MGRX
MANGOCEUTICALS, INC.
Dec 9, 2025
Sale(S)
Direct
5K shares at avg. $1.20$6K
MGRX
MANGOCEUTICALS, INC.
Dec 5, 2025
Sale(S)
Direct
10K shares at avg. $1.13$11K
MGRX
MANGOCEUTICALS, INC.
Sep 9, 2025
Award(A)
Direct
100K shares-
MGRX
MANGOCEUTICALS, INC.
Nov 11, 2024
Award(A)
Direct
25K shares-

		Type	Shares	Price		Ownership
Jul 28, 2026	MGRX MANGOCEUTICALS, INC.	Award(A)	100,000	-	$0	Direct
Dec 15, 2025	MGRX MANGOCEUTICALS, INC.	Sale(S)	3,333	$1.17	$3,884	Direct
Dec 9, 2025	MGRX MANGOCEUTICALS, INC.	Sale(S)	5,000	$1.20	$5,975	Direct
Dec 5, 2025	MGRX MANGOCEUTICALS, INC.	Sale(S)	10,000	$1.13	$11,280	Direct
Sep 9, 2025	MGRX MANGOCEUTICALS, INC.	Award(A)	100,000	-	-	Direct
Nov 11, 2024	MGRX MANGOCEUTICALS, INC.	Award(A)	25,000	-	$0	Direct

1-6 of 6 transactions

About JOHNSTON EUGENE M

JOHNSTON EUGENE M (SEC CIK 0001254538) files insider reports with the SEC as Chief Financial Officer of OFA Group (OFAL) and CFO of MANGOCEUTICALS, INC. (MGRX).

Signal8 holds 7 ownership filings by JOHNSTON EUGENE M (1 Form 3, 6 Form 4), filed between Nov 12, 2024 and Oct 9, 2026. Those filings report 6 transactions, from Nov 11, 2024 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on JOHNSTON EUGENE M's filings is in DALLAS, TX.

Recent filings by JOHNSTON EUGENE M

Jul 28, 2026: Grant or award of MGRX shares (Form 4, code A).
Dec 15, 2025: Open-market sale of MGRX shares (Form 4, code S).
Dec 9, 2025: Open-market sale of MGRX shares (Form 4, code S).
Dec 5, 2025: Open-market sale of MGRX shares (Form 4, code S).
Sep 9, 2025: Grant or award of MGRX shares (Form 4, code A).

Other insiders filing for OFA Group (OFAL)

Gaffney Thomas Michael, Chief Operations Officer
chong wai wong, Chief Technology Officer
wong li hsien, Chief Executive Officer
R-OPUS Inc., 10% Owner
Chiang John, Director

How to read Form 4 transaction codes